Arteris VP GC sells 6,500 shares, exercises options
Arteris, Inc. VP and General Counsel Paul L. Alpern reported multiple transactions in the company’s common stock on July 1, 2026.
Rhea-AI Filing Summary
Arteris, Inc. VP and General Counsel Paul L. Alpern reported multiple transactions in the company’s common stock on July 1, 2026. He sold a total of 6,500 shares in open-market transactions at weighted average prices ranging from about $43.70 to $47.50, carried out under a pre-arranged Rule 10b5-1 trading plan adopted on February 23, 2026. On the same date, he exercised stock options to acquire 6,500 shares of common stock at exercise prices of $9.28 and $0.56 per share. Following these transactions, he continues to hold more than 80,000 shares of Arteris common stock directly.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 6,500 shares ($270K approx. pre-tax spread)
Exercise and Sale
8 txns
Insider
Alpern Paul L
Role
VP and General Counsel
Sold
6,500 shs ($296K)
Approx. gross sale proceeds
$296K
Approx. exercise cost
$25K
Approx. pre-tax spread
$270K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Incentive Stock Option (right to buy) | 4,000 | $0.00 | $0.00 |
| Exercise | Non-Qualified Stock Option (right to buy) | 2,500 | $0.00 | $0.00 |
| Exercise | Common Stock | 4,000 | $0.56 | $2K |
| Exercise | Common Stock | 2,500 | $9.28 | $23K |
| Sale | Common Stock | 2,096 | $44.0182 | $92K |
| Sale | Common Stock | 983 | $45.0793 | $44K |
| Sale | Common Stock | 2,521 | $46.2265 | $117K |
| Sale | Common Stock | 900 | $47.1131 | $42K |
Holdings After Transaction:
Incentive Stock Option (right to buy) — 57,000 contracts (Direct);
Non-Qualified Stock Option (right to buy) — 25,000 contracts (Direct);
Common Stock — 80,384 shares (Direct)
Footnotes (7)
- F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on February 23, 2026.
- F2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.70 to $44.69 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.81 to $45.79 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $45.815 to $46.51 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.85 to $47.50 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. Incentive stock option, 25% of the total shares vested on August 26, 2020; thereafter, 1/48th of the total shares vested monthly for 3 years, beginning on September 26, 2020.
- F7. Non-qualified stock options, vesting in 16 equal quarterly installments of 1/16th each, beginning on April 1, 2025.
Key Figures
Shares sold: 6,500 shares
Shares from option exercises: 6,500 shares
Sale price range: $43.70–$47.50 per share
+4 more
7 metrics
Shares sold
6,500 shares
Total Arteris common stock sold on July 1, 2026
Shares from option exercises
6,500 shares
Common shares acquired through option exercises on July 1, 2026
Sale price range
$43.70–$47.50 per share
Weighted average sale prices across multiple transactions
Incentive option strike price
$0.56 per share
Exercise price for 4,000 incentive stock option shares
Non-qualified option strike price
$9.28 per share
Exercise price for 2,500 non-qualified stock option shares
Shares held after transactions
Over 80,000 shares
Direct Arteris common stock holdings following reported trades
10b5-1 plan adoption date
February 23, 2026
Date Alpern adopted the trading plan used for these sales
Key Terms
Rule 10b5-1 trading plan, weighted average sale price, Incentive stock option, Non-qualified stock options, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sale price financial
"The price reported in Column 4 is a weighted average sale price."
Incentive stock option financial
"Incentive stock option, 25% of the total shares vested on August 26, 2020"
An incentive stock option is a type of employee benefit that gives a worker the right to buy company shares at a fixed price, with special tax advantages if the employee holds the shares for a required period. Think of it as a coupon to buy future shares at today’s price that can result in lower tax on the gain. Investors care because ISOs can dilute share count, align staff incentives with the stock price, and affect company compensation costs and the timing of potential share sales.
Non-qualified stock options financial
"Non-qualified stock options, vesting in 16 equal quarterly installments"
Non-qualified stock options are a type of employee benefit that gives individuals the right to buy company shares at a set price, usually lower than the market value, within a certain period. Unlike other options that may have special tax advantages, these options are taxed as income when exercised, which can affect how much money the employee or investor ultimately gains. They are important because they can influence company compensation strategies and impact the financial outcomes for employees and investors.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
What insider transactions did Arteris (AIP) VP and General Counsel Paul L. Alpern report?
Paul L. Alpern reported selling 6,500 shares of Arteris common stock and exercising options for 6,500 shares. The sales were open-market transactions, while the exercises converted stock options into common shares on the same date.
Were Paul L. Alpern’s Arteris (AIP) stock sales made under a Rule 10b5-1 plan?
Yes. A footnote states the transactions were made pursuant to a Rule 10b5-1 trading plan adopted on February 23, 2026. Such pre-arranged plans automate trading and can reduce the significance of transaction timing as a signal.
What stock options did Paul L. Alpern exercise in this Arteris (AIP) Form 4?
He exercised options covering 6,500 shares of Arteris common stock. This included 2,500 non-qualified stock option shares with a $9.28 exercise price and 4,000 incentive stock option shares with a $0.56 exercise price.
What are the key terms of Paul L. Alpern’s Arteris (AIP) stock option grants?
One incentive stock option vested 25% on August 26, 2020, with the remainder vesting monthly over three years. A non-qualified option vests in 16 equal quarterly installments beginning April 1, 2025, according to the disclosed vesting footnotes.
AI-generated analysis. How Rhea-AI works. Not financial advice.
